• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用铝佐剂-海藻酸钠增强 RBD-FC 的免疫原性以对抗 SARS-COV-2。

Improvement of RBD-FC Immunogenicity by Using Alum-Sodium Alginate Adjuvant Against SARS-COV-2.

机构信息

Department of Cellular and Molecular Biology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.

Protein Research Center, Shahid Beheshti University, Tehran, Iran.

出版信息

Influenza Other Respir Viruses. 2024 Nov;18(11):e70018. doi: 10.1111/irv.70018.

DOI:10.1111/irv.70018
PMID:39478310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11525037/
Abstract

BACKGROUND

Adjuvants use several mechanisms to boost immunogenicity and to modulate immune response. The strength of adsorption of antigen by adjuvants can be a determinant factor for significant improvement of immunopotentiation.

METHODS

We expressed recombinant RBD-FC in PichiaPink Strain 4 and examined the vaccination of mice by vaccine formulation with different adjuvants (sodium alginate and aluminum hydroxide, alone and together).

RESULTS

Sodium alginate significantly increased the immunogenicity and stability of RBD-FC antigen, so RBD-FC formulated with combined alginate and alum (AlSa) and sodium alginate alone showed higher antibody titer and stability. Immunogenicity of RBD-FC:AlSa was determined by serological assays including direct enzyme-linked immunosorbent assay (ELISA) and surrogate virus neutralization test (sVNT). High levels of IgGs and neutralizing antibodies were measured in serum of mice immunized with the RBD-FC:AlSa formulation. On the other hand, cytokines IL-10 and INF-γ were severely accumulated in response to RBD-FC:AlSa, and after 10 days, their accumulation was significantly declined, whereas IL-4 showed the highest and the lowest accumulation in response to alum and alginate, respectively.

CONCLUSIONS

Our data may suggest that combination of alum and sodium alginate has a better compatibility with RBD-FC in vaccine formulation.

摘要

背景

佐剂通过多种机制增强免疫原性并调节免疫反应。佐剂对抗原的吸附强度可能是显著增强免疫的决定因素。

方法

我们在毕赤酵母Pink 菌株 4 中表达了重组 RBD-FC,并通过用不同佐剂(藻酸钠和氢氧化铝,单独和组合)配制的疫苗来检查小鼠的疫苗接种。

结果

藻酸钠显著提高了 RBD-FC 抗原的免疫原性和稳定性,因此 RBD-FC 与藻酸钠和明矾(AlSa)组合以及单独的藻酸钠配制的疫苗显示出更高的抗体滴度和稳定性。RBD-FC 的免疫原性:通过血清学检测包括直接酶联免疫吸附测定(ELISA)和替代病毒中和试验(sVNT)来确定。用 RBD-FC:AlSa 制剂免疫的小鼠血清中测量到高水平的 IgG 和中和抗体。另一方面,细胞因子 IL-10 和 INF-γ在对 RBD-FC:AlSa 的反应中严重积累,并且在 10 天后,其积累明显下降,而 IL-4 对明矾和藻酸钠的反应分别显示出最高和最低的积累。

结论

我们的数据可能表明,明矾和藻酸钠的组合在疫苗配方中与 RBD-FC 具有更好的相容性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/a1cd595de98d/IRV-18-e70018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/7fbce31d61f0/IRV-18-e70018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/ceae8e23521c/IRV-18-e70018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/b0209f08a725/IRV-18-e70018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/bb8d0b2083af/IRV-18-e70018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/60e2d25a778a/IRV-18-e70018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/97f3d6fff214/IRV-18-e70018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/a1cd595de98d/IRV-18-e70018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/7fbce31d61f0/IRV-18-e70018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/ceae8e23521c/IRV-18-e70018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/b0209f08a725/IRV-18-e70018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/bb8d0b2083af/IRV-18-e70018-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/60e2d25a778a/IRV-18-e70018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/97f3d6fff214/IRV-18-e70018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b8d/11525037/a1cd595de98d/IRV-18-e70018-g002.jpg

相似文献

1
Improvement of RBD-FC Immunogenicity by Using Alum-Sodium Alginate Adjuvant Against SARS-COV-2.利用铝佐剂-海藻酸钠增强 RBD-FC 的免疫原性以对抗 SARS-COV-2。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70018. doi: 10.1111/irv.70018.
2
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.优化严重急性呼吸综合征冠状病毒2(SARS-CoV-2)亚单位疫苗组合物的免疫原性和产品呈现:给药途径、与自我扩增RNA疫苗的异源方案以及冻干的影响
Front Immunol. 2024 Dec 16;15:1480976. doi: 10.3389/fimmu.2024.1480976. eCollection 2024.
3
Aluminum hydroxide and immunostimulatory glycolipid adjuvant combination for enhanced COVID-19 subunit vaccine immunogenicity.氢氧化铝和免疫刺激性糖脂佐剂组合增强 COVID-19 亚单位疫苗免疫原性。
Vaccine. 2024 Aug 30;42(21):126145. doi: 10.1016/j.vaccine.2024.07.046. Epub 2024 Jul 20.
4
Boosting the immune response in COVID-19 vaccines via an Alum:CpG complex adjuvant.通过明矾:CpG复合物佐剂增强COVID-19疫苗中的免疫反应。
Antiviral Res. 2024 Sep;229:105954. doi: 10.1016/j.antiviral.2024.105954. Epub 2024 Jul 2.
5
An Evaluation of the Cellular and Humoral Response of a Multi-Epitope Vaccine Candidate Against COVID-19 with Different Alum Adjuvants.一种针对COVID-19的多表位候选疫苗与不同铝佐剂的细胞和体液反应评估。
Pathogens. 2024 Dec 9;13(12):1081. doi: 10.3390/pathogens13121081.
6
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.一种使用 3M-052 佐剂配制的基于酵母表达 RBD 的 SARS-CoV-2 疫苗可在非人类灵长类动物中促进保护效力。
Sci Immunol. 2021 Jul 15;6(61). doi: 10.1126/sciimmunol.abh3634.
7
Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice.新型冠状病毒刺突蛋白疫苗 S1 亚单位佐剂可改善小鼠的抗体和 T 细胞应答及替代中和作用。
Sci Rep. 2024 Nov 28;14(1):29609. doi: 10.1038/s41598-024-80636-3.
8
Hybrid response to SARS-CoV-2 and C after an OMV-adjuvanted immunization in mice and their offspring.在小鼠及其后代中,用 OMV 佐剂免疫后对 SARS-CoV-2 和 C 的混合反应。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2346963. doi: 10.1080/21645515.2024.2346963. Epub 2024 May 15.
9
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.佐剂 COVID-19 亚单位疫苗以诱导保护性免疫。
Nature. 2021 Jun;594(7862):253-258. doi: 10.1038/s41586-021-03530-2. Epub 2021 Apr 19.
10
Development of a two-component recombinant vaccine for COVID-19.一种用于新型冠状病毒肺炎的双组分重组疫苗的研发。
Front Immunol. 2024 Dec 20;15:1514226. doi: 10.3389/fimmu.2024.1514226. eCollection 2024.

本文引用的文献

1
Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system.通过安全的天然佐剂系统增强针对 SARS-CoV-2 受体结合域的中和抗体。
Virus Res. 2023 Mar;326:199047. doi: 10.1016/j.virusres.2023.199047. Epub 2023 Jan 21.
2
Adjuvants to increase immunogenicity of SARS-CoV-2 RBD and support maternal-fetal transference of antibodies in mice.佐剂增强 SARS-CoV-2 RBD 的免疫原性,并支持抗体在小鼠中的母胎转移。
Pathog Dis. 2022 Oct 19;80(1). doi: 10.1093/femspd/ftac038.
3
An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD).
对 SARS-CoV-2 刺突受体结合域(RBD)的进化和结构特征的综合理解。
Int J Biol Macromol. 2022 Sep 30;217:492-505. doi: 10.1016/j.ijbiomac.2022.07.022. Epub 2022 Jul 13.
4
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.SARS-CoV-2 感染会导致呼吸道和外周血中的免疫反应,这些反应提示了疾病严重程度的机制。
Nat Commun. 2022 May 19;13(1):2774. doi: 10.1038/s41467-022-30088-y.
5
Biocompatible Films of Calcium Alginate Inactivate Enveloped Viruses Such as SARS-CoV-2.海藻酸钙生物相容性薄膜可灭活诸如SARS-CoV-2等包膜病毒。
Polymers (Basel). 2022 Apr 6;14(7):1483. doi: 10.3390/polym14071483.
6
Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses.在 COVID-19 大流行和主要人类致病病毒的背景下,利用天然来源衍生的硫酸化多糖的抗病毒策略。
Viruses. 2021 Dec 24;14(1):35. doi: 10.3390/v14010035.
7
Antiviral Properties of Alginate-Based Biomaterials: Promising Antiviral Agents against SARS-CoV-2.基于海藻酸盐的生物材料的抗病毒特性:针对 SARS-CoV-2 的有前途的抗病毒药物。
ACS Appl Bio Mater. 2021 Aug 16;4(8):5897-5907. doi: 10.1021/acsabm.1c00523. Epub 2021 Jul 13.
8
Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.酵母生产的基于受体结合域(RBD)的重组蛋白疫苗可引发广泛中和抗体,并对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染产生持久的保护性免疫。
Cell Discov. 2021 Aug 18;7(1):71. doi: 10.1038/s41421-021-00315-9.
9
Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review.壳聚糖、海藻酸盐、透明质酸、胶、β-葡聚糖作为 SARS-CoV-2 等病毒威胁的有效佐剂和疫苗传递系统:综述。
Int J Biol Macromol. 2021 Jul 1;182:1931-1940. doi: 10.1016/j.ijbiomac.2021.05.155. Epub 2021 May 25.
10
An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.细胞因子风暴中心鉴定的相互关联细胞因子网络可预测 COVID-19 预后。
Cytokine. 2021 Feb;138:155365. doi: 10.1016/j.cyto.2020.155365. Epub 2020 Nov 9.